Health Coverage for IVF Act of 2025

Bill Number

H.R. 3480

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-05-19: Referred to the House Committee on Energy and Commerce.

Last Updated

2025-05-29T15:10:24Z

AI-Generated Summary

Purpose

The legislation, titled the "Health Coverage for Inclusive and Valued Families Act of 2025" or "Health Coverage for IVF Act of 2025," aims to expand access to fertility treatments by requiring health insurance plans to cover them as an essential health benefit under the Patient Protection and Affordable Care Act (ACA). This ensures that fertility care is treated like other core medical services, promoting equity in reproductive health coverage.

Key Provisions

• Addition to Essential Health Benefits (EHBs): Amends the ACA to include "fertility treatment and care" as a new EHB category. EHBs are a set of 10 basic health services that most insurance plans must cover without excessive limits or costs.
• Definition of Fertility Treatment and Care: Covers medically appropriate services such as:
• Preservation of eggs (oocytes), sperm, or embryos for future use.
• Artificial insemination methods (e.g., intrauterine insemination).
• Assisted reproductive technologies like in vitro fertilization (IVF), including at least three egg retrieval cycles and unlimited embryo transfers, following guidelines from the American Society for Reproductive Medicine (which emphasizes single embryo transfers when safe).
• Genetic testing of embryos.
• Medications for fertility.
• Egg or sperm donation.
• Other related services, referrals, tests, or technologies as determined by the Secretary of Health and Human Services (HHS).
• Coverage Requirements for Plans: For individual and small group health plans that include medical/surgical benefits:
• Financial rules (e.g., deductibles, copays) for fertility care cannot be stricter than those for most other medical benefits; no separate cost-sharing just for fertility.
• Limits on treatments (e.g., number of visits) cannot be more restrictive than for other benefits; no fertility-specific limits.
• Prohibition on Denials: Insurers cannot deny fertility benefits to individuals without a formal infertility diagnosis.
• Utilization Management Oversight: Insurers using tools to manage fertility care usage (e.g., prior authorizations) must analyze and report on them annually for the first five years after enactment (and ongoing if requested). Reports go to HHS and the Government Accountability Office (GAO), covering terms, factors, evidence standards, and compliance with clinical guidelines. The GAO must submit public reports to Congress summarizing compliance.
• Effective Date: Applies to health plan years starting at least one year after the bill's enactment.

Significant Changes to Existing Law

• Expansion of EHBs: Previously, the ACA's EHBs did not explicitly include fertility treatments, leaving coverage optional or limited in many plans. This bill adds fertility as a mandatory 11th category, aligning it with existing EHBs like maternity care or mental health services.
• Parity in Coverage: Introduces "parity" rules (equal treatment) for fertility benefits, similar to existing mental health parity laws, preventing insurers from imposing unique barriers.
• Reporting Mandates: Adds new federal oversight through insurer analyses and GAO reports, which did not exist for fertility care under prior law.
• Broadened Access: Removes the infertility diagnosis barrier, extending coverage to those pursuing family-building options like IVF for non-medical reasons (e.g., delayed parenthood).

Potential Impacts

• On Citizens: Increases access to costly fertility treatments (e.g., IVF can exceed $15,000 per cycle), reducing financial barriers for individuals and couples building families. Could benefit about 1 in 8 couples facing infertility, plus others using preservation or donation, potentially lowering out-of-pocket costs and improving reproductive equity.
• On Government Agencies: HHS gains authority to define additional services and review insurer reports; GAO must produce compliance reports, adding administrative workload but enhancing transparency.
• On Health Insurers and Employers: Insurers in individual/small group markets must update plans, potentially raising premiums slightly due to added coverage costs (estimated at 1-2% increase per some studies). Small businesses offering group plans may see indirect effects if premiums rise.
• On International Relations: Minimal direct impact, though it could position the U.S. as more aligned with countries (e.g., in Europe) that subsidize fertility care, influencing global health policy discussions.

Main Stakeholders Affected

• Individuals and Families: Primary beneficiaries, especially those aged 25-44 seeking fertility services, including LGBTQ+ individuals, single parents, and those delaying parenthood.
• Health Insurers: Must comply with new mandates, affecting coverage design and costs in the individual and small group markets (not large employer plans).
• Healthcare Providers: Fertility clinics and specialists (e.g., reproductive endocrinologists) may see increased patient volume and reimbursements.
• Government Entities: HHS (oversight and definitions), GAO (reporting), and Congress (receiving compliance updates).
• Advocacy Groups: Organizations like Resolve: The National Infertility Association or women's health advocates, who may monitor implementation.

Notable Legal, Constitutional, or Political Implications

• Legal: Strengthens ACA frameworks by expanding EHBs without altering the law's core structure; enforceable through HHS regulations and potential lawsuits for non-compliance. The infertility diagnosis prohibition could face challenges if seen as overreaching insurer discretion, but it aligns with anti-discrimination principles in health law.
• Constitutional: No direct conflicts; supports equal protection under the 14th Amendment by addressing disparities in reproductive access, though it may invite debates on federal vs. state authority over insurance (states define EHBs within federal guidelines).
• Political: Advances reproductive rights amid ongoing debates on family policy and IVF access (e.g., post-Roe v. Wade landscape). Could polarize along partisan lines, with support from Democrats emphasizing equity and opposition from conservatives citing costs or moral concerns about IVF. As an amendment to the ACA, it risks repeal efforts if the law faces broader challenges.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Underwood, Lauren [D-IL-14]

Recent Actions

• 2025-05-19: Referred to the House Committee on Energy and Commerce.
• 2025-05-19: Introduced in House
• 2025-05-19: Introduced in House

Bill Versions

• Health Coverage for Inclusive and Valued Families Act of 2025 — issued 2025-05-19 — PDF (7 pages)